Pieper Steven (CIK 1875714) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Sell XERS (17,400 shares), Sell XERS (27,600 shares), Buy XERS (27,891 shares), Buy XERS (14,036 shares), Buy XERS (154,986 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 17,400 | $147,900 |
| 2026-07-07 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 27,600 | $235,276 |
| 2026-03-05 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Buy | 27,891 | $114,074 |
| 2026-03-05 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Buy | 14,036 | $83,233 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Buy | 154,986 | $0 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 111,765 | $822,590 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 66,450 | $489,072 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 27,319 | $201,068 |
| 2025-02-03 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 110,750 | $394,270 |
| 2025-02-03 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 66,450 | $236,562 |
| 2025-02-03 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Buy | 185,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-07